Tag Archives: Genetic

Courtagen-Life-sciences

Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S.

Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S.

WOBURN, Mass., Feb. 23, 2017 /Weed Wire/ — Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or Suffering from TRAP1 Change-of-Function.”

Esev Aphira

ESEV Genetics Scores With Canada’s Aphria to Create Strongest Strains

LEAMINGTON, Ontario, Feb. 1, 2016 /Weed Wire/ — Aphria Inc (TSX VENTURE:APH), one of Canada’s leading large scale producers of medical-grade cannabis, partners with pioneering ESEV Genetics to develop and bring to market the highest quality strains of cannabis available to treat a range of medical conditions.


Top